10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 314 filers reported holding 10X GENOMICS INC in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,013 | -32.5% | 170,000 | -8.7% | 0.79% | -22.4% |
| Q2 2023 | $10,394 | -99.9% | 186,143 | 0.0% | 1.02% | -6.5% |
| Q1 2023 | $10,384,918 | +53.1% | 186,143 | 0.0% | 1.09% | +29.7% |
| Q4 2022 | $6,783,051 | +28.0% | 186,143 | 0.0% | 0.84% | +27.4% |
| Q3 2022 | $5,301,000 | -37.1% | 186,143 | 0.0% | 0.66% | -32.3% |
| Q2 2022 | $8,423,000 | -40.5% | 186,143 | 0.0% | 0.98% | -31.8% |
| Q1 2022 | $14,160,000 | -48.9% | 186,143 | 0.0% | 1.43% | -45.1% |
| Q4 2021 | $27,728,000 | +2.3% | 186,143 | 0.0% | 2.60% | +63.9% |
| Q3 2021 | $27,099,000 | -25.7% | 186,143 | 0.0% | 1.59% | -24.3% |
| Q2 2021 | $36,451,000 | +125.1% | 186,143 | +108.0% | 2.10% | +131.7% |
| Q1 2021 | $16,195,000 | – | 89,476 | – | 0.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 750,000 | $111,720,000 | 99.68% |
| Foresite Capital Management II, LLC | 1,753,528 | $261,206,000 | 99.34% |
| Venrock Management VI, LLC | 962,309 | $143,346,000 | 96.17% |
| 12 West Capital Management LP | 2,004,000 | $298,516,000 | 13.24% |
| FINANCIAL CONSULATE, INC | 154,942 | $23,080,000 | 8.00% |
| Meritech Capital Associates V L.L.C. | 1,610,824 | $239,948,000 | 7.68% |
| Andar Capital Management HK Ltd | 55,000 | $8,193,000 | 7.52% |
| JS Capital Management LLC | 540,589 | $80,526,000 | 3.66% |
| HARVARD MANAGEMENT CO INC | 186,143 | $27,728,000 | 2.60% |
| Connective Portfolio Management, LLC | 7,000 | $1,056,000 | 1.86% |